 |
Biosketch
Lawrence Wagman, M.D., leads both the clinical and research sections of the Liver Tumor Program at City of Hope (COH). His clinical research focuses on the treatment of primary liver tumors., as well as chemoprevention of breast cancer, colorectal cancer metastatic to the liver, and management of surgical challenges unique to bone marrow transplantation. Dr. Wagman\'s oncologic surgical expertise also include s breast, head and neck, and gastrointestinal cancer.
Wagman is the primary investigator on the Study of Tamoxifen and Raloxifen (STAR Trial) one of the largest breast cancer prevention studies ever, which recently closed to accrual at City of Hope. Further, he has co-authored a book on the multidisciplinary management of cancer, and has authored or co-authored more than 50 journal articles, 11 book chapters and 40 abstracts.
Affiliation
- Chair, Division of Surgery
City of Hope National Medical Center
Duarte, California
|